Exactech recalled 11,542 reverse shoulder humeral liners on August 15, 2025. The devices have an articular surface position outside of the specified dimensions. This recall affects units distributed worldwide, including several U.S. states.
Reverse Shoulder humeral liners have an articular surface position outside of the dimensional specification within the labeling.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Exactech, Inc. or your healthcare provider for instructions. Notification method: E-Mail
The recall includes Exactech Equinoxe Reverse Shoulder Humeral Liners with model references 322-38-00, 322-38-03, 322-42-00, and 322-42-03. These liners were distributed in various countries, including Australia, Canada, and the United Kingdom.
The reverse shoulder humeral liners have an incorrect articular surface position, which may lead to serious complications for patients. This recall falls under Class II, indicating a high risk of injury.
Currently, there are no reported injuries or incidents directly linked to this defect. The recall is a precautionary measure.
Patients and healthcare providers should stop using these liners immediately. Contact Exactech, Inc. or your healthcare provider for further instructions.
For more information, visit Exactech's website or contact them via email. Additional details are available at the FDA's recall page.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.